Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP828953.RAQWU1H7a58cRfnor1MKTuQrwhUfu50bFpDRee9iCKt2k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP828953.RAQWU1H7a58cRfnor1MKTuQrwhUfu50bFpDRee9iCKt2k130_assertion type Assertion NP828953.RAQWU1H7a58cRfnor1MKTuQrwhUfu50bFpDRee9iCKt2k130_head.
- NP828953.RAQWU1H7a58cRfnor1MKTuQrwhUfu50bFpDRee9iCKt2k130_assertion description "[Under HG, there was a twofold increase in the expression of CAT, CuZnSOD, and GPX mRNA in the patients without complications and the control subjects versus patients with nephropathy (P < 0.0001), and MnSOD did not change in any of the groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP828953.RAQWU1H7a58cRfnor1MKTuQrwhUfu50bFpDRee9iCKt2k130_provenance.
- NP828953.RAQWU1H7a58cRfnor1MKTuQrwhUfu50bFpDRee9iCKt2k130_assertion evidence source_evidence_literature NP828953.RAQWU1H7a58cRfnor1MKTuQrwhUfu50bFpDRee9iCKt2k130_provenance.
- NP828953.RAQWU1H7a58cRfnor1MKTuQrwhUfu50bFpDRee9iCKt2k130_assertion SIO_000772 12606529 NP828953.RAQWU1H7a58cRfnor1MKTuQrwhUfu50bFpDRee9iCKt2k130_provenance.
- NP828953.RAQWU1H7a58cRfnor1MKTuQrwhUfu50bFpDRee9iCKt2k130_assertion wasDerivedFrom befree-20140225 NP828953.RAQWU1H7a58cRfnor1MKTuQrwhUfu50bFpDRee9iCKt2k130_provenance.
- NP828953.RAQWU1H7a58cRfnor1MKTuQrwhUfu50bFpDRee9iCKt2k130_assertion wasGeneratedBy ECO_0000203 NP828953.RAQWU1H7a58cRfnor1MKTuQrwhUfu50bFpDRee9iCKt2k130_provenance.